[Clinical experimentation of the thiabendazole and tetramizole cyclamate combination in the treatment of human enteroparasitosis].
D000293:Adolescent; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D003494:Cyclamates / Q000627:therapeutic use; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D008297:Male; D009349:Nematode Infections / Q000188:drug therapy; D011528:Protozoan Infections / Q000188:drug therapy*; D013827:Thiabendazole / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D003494:Cyclamates; D013844:Thiazoles; D013827:Thiabendazole
Experimentação clínica da associação do tiabendazol e ciclamato de tetramisol no tratamento das enteroparasitoses humanas.